Oxidatively modified autoantigens in autoimmune diseases

Area of Science:

• Biochemistry
• Immunology
• Pathology

Background:

• Free radical-mediated oxidative damage and subsequent protein modification by end products are key in cell toxicity and disease.
• Aldehydic products, such as 4-hydroxy-2-alkenals, form immunogenic adducts with proteins.
• Oxidative modification of proteins, DNA, and LDL is linked to various autoimmune diseases.

Purpose of the Study:

• To review the role of oxidative damage and protein modification in autoimmunity.
• To highlight the association of specific oxidative modifications with diseases like SLE, DM, and RA.
• To explore the potential of antioxidant administration in managing autoimmune diseases.

Main Methods:

• Review of existing literature on oxidative stress and autoimmune disease pathogenesis.
• Analysis of studies linking specific oxidative modifications (e.g., 4-HNE, 8-oxodG, AGEs, oxidized LDL) to disease markers and autoantibodies.
• Examination of animal models demonstrating the role of oxidative damage in autoimmune responses.

Main Results:

• Oxidative modification of proteins, DNA, and LDL is prevalent in systemic lupus erythematosus (SLE), diabetes mellitus (DM), and rheumatoid arthritis (RA).
• Specific modifications like 4-hydroxy-2-nonenal (HNE)-modified proteins and advanced glycation end product (AGE) pentosidine correlate with disease activity.
• Autoantibodies against oxidized components are found in various autoimmune conditions, including Behcet's disease and scleroderma.

Conclusions:

• Oxidative damage and subsequent protein modification play a significant role in the pathogenesis of autoimmune diseases.
• The presence of autoantibodies against oxidized molecules is a common feature across multiple autoimmune disorders.
• Antioxidant administration presents a potential, though currently under-explored, therapeutic strategy for autoimmune diseases.